Lindsey D. Mayo
Affiliations: | Biochemistry and Molecular Biology | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
Molecular Biology, Biochemistry, General BiologyGoogle:
"Lindsey Mayo"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chen S, Wang Q, Yu H, et al. (2020) Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway. Nature Communications. 11: 3856 |
Wolf ER, Mabry AR, Damania B, et al. (2020) Mdm2-mediated neddylation of pVHL blocks the induction of antiangiogenic factors. Oncogene |
Chen S, Wang Q, Yu H, et al. (2019) Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway. Nature Communications. 10: 5649 |
Nabinger SC, Chen S, Gao R, et al. (2019) Mutant p53 enhances leukemia-initiating cell self-renewal to promote leukemia development. Leukemia |
Wang J, Shen T, Zhu W, et al. (2018) Protein phosphatase 5 and the tumor suppressor P53 down-regulate each other's activities in mice. The Journal of Biological Chemistry |
Olivos DJ, Perrien DS, Hooker A, et al. (2018) The proto-oncogene function of Mdm2 in bone. Journal of Cellular Biochemistry |
Wolf ER, McAtarsney CP, Bredhold KE, et al. (2018) Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK. Science Signaling. 11 |
Chen S, Gao R, Yao C, et al. (2017) Genotoxic stresses promote clonal expansion of hematopoietic stem cells expressing mutant p53. Leukemia |
Hauck PM, Wolf ER, Olivos DJ, et al. (2017) The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2). Oncotarget. 8: 104455-104466 |
Hauck P, Wolf E, Olivos D, et al. (2017) Early Stage Metastasis require Mdm2 and not p53 Gain of Function. Molecular Cancer Research : McR |